+1-786-628-7980
Sign Up/Sign In 
Cell Therapy Market Research Report Information By Cell Type (Stem Cell and Non-Stem Cell), By Therapy Type (Autologous and Allogeneic), By Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), By End User (Hospitals & Clinics and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032
The Cell Therapy market industry is projected to grow from USD 14.8 Billion in 2023 to USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2023 – 2032). To treat disorders, cell therapy involves transplanting cells into the patient’s body. These cells can come from the patient’s own body and are referred to as autologous cells, or they can come from many donors and are referred to as allogeneic cells. Multipotent cells can differentiate into various cell types, whereas pluripotent cells can differentiate into any type of cell in the body. Even yet, they have a more limited repertoire than pluripotent cells. The type of primary cells is fixed.
The sort of treatment determines the kind of cells that are given. Replacement stem cells are either stem cells or come from stem cells. The development of clinical research into the creation of cellular therapies, the expanding use of cell regeneration therapy, and the introduction of fresh platforms and technologies all point to an upward trend in the market forecast for cell therapy. CAR T cell therapy is the name given to a method of treating cancer by regenerating white blood cells (WBCs). Cell and gene therapies are combined in CAR T-cell therapy.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/5066
Covid 19 Impact
The COVID-19 pandemic has a favorable effect on the expansion of the cell therapy market. The epidemic gave cell treatments a boost in the market. For instance, Calidi Biotherapeutics Inc. revealed in April 2020 that the FDA had approved the Investigational New Drug application submitted by its partner, Personalized Stem Cells, Inc., for the use of stem cell therapy in the diagnosis and treatment of COVID-19 patients. As a result, this helped the market for cell treatment flourish.
The prevalence of chronic illnesses and infections is one of the market trends for cell treatment. The market for cell treatment is also being driven by rising diabetes rates and increased regenerative medicine use. The International Diabetes Federation Diabetes Atlas estimates that 573 million people worldwide had diabetes in 2021, and that number will increase to 643 million by 2030. Additionally, the expansion of the cell therapy market is being supported by an increase in research studies and clinical trials.
Market Segmentation
Based on cell type, the market for cell treatment is divided into stem cells, non-stem cells, bone marrow, blood, umbilical cord-derived stem cells, adipose-derived stem cells, and others (placenta, and nonspecific cells). In 2021, the category of stem cell therapy retained a sizable market share due to the rising need for effective and new treatments for autoimmune, neurological, and cardiovascular diseases. Cell regeneration treatment is another name for stem cell therapy. However, the category with the quickest rate of growth over the anticipated period is non-stem cells. Non-stem cell therapy can increase the production of collagen and the creation of new, healthy skin tissue.
Based on the type of therapy, there are autologous and allogeneic market sectors for cell therapy. Due to several benefits of autologous transplants, including their accessibility, lack of requirement for finding an HLA-matched donor, reduced risk of life-threatening complications, absence of GVHD risk, and lack of requirement for immunosuppressive therapy, the autologous category had a sizable share in 2021. However, due to the expensive cost of allogeneic transplants and relatively low relapse rates, the allogeneic category is expanding at the quickest rate.
Based on the therapeutic area, the cell therapy market research includes studies on cancer, musculoskeletal disorders, autoimmune diseases, dermatology, and other conditions. Due to a rise in the use of cell therapy to treat malignancies, the category of malignancies had a sizable proportion in 2021. Aside from that, the fastest-growing category is musculoskeletal illnesses since chronic conditions like atherosclerosis are becoming more common.
According to the cell therapy market report, academia and research institutions, hospitals, and clinics make up the end users. Due to the rising demand for gene and cell therapy during the anticipated period, hospitals and clinics maintained a significant market share in 2021. However, the category with the fastest growth is academic and research institutions. The major purpose of the stem cells is research, which has resulted in a sizable income share.
Regional Analysis
The North American, European, Asia-Pacific, and Rest of the World regions make up the market. The largest share of the market was in North America. The region with the highest expected CAGR over the study period is Asia-Pacific.
Browse In-depth Market Research Report (95 Pages) on Cell Therapy:
https://www.marketresearchfuture.com/reports/cell-therapy-market-5066
In 2021, the market was dominated by North America because of rising rates of chronic diseases and rising market development spending. In January 2022, Cellino Biotech, an independent manufacturer of cell treatments, secured a first financing round for USD 80 million. By 2025, Cellino hopes to have the first self-contained human cell foundry built, making stem cell-based medications more accessible. Additionally, the market in the North American region is being stimulated by an increase in the use of stem cell technology for medical purposes.
Discover More Research Reports on Healthcare Industry by Market Research Future:
During the projected period, Asia-Pacific is anticipated to grow at the fastest rate. The Asia-Pacific market is dominated by China. The market in this area is expanding in part because of favorable government rules. With a population of about 4.6 billion as of 2019, Asia-Pacific has a huge potential for market expansion and could serve as a patient base in the future. Additionally, growth is anticipated in developing nations like China and India because of their improved healthcare infrastructure, affordable healthcare, and growing understanding of cell therapy.
Competitive Analysis
There are tier-1, tier-2, and local players in the market. The tier-1 and tier-2 players are well-known and have a wide range of products. Because of their distinctive products, financial stability, strategic developments, and diversified regional presence, businesses like Mesoblast Ltd., Vericel Corporation, Osiris Therapeutics, Inc., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., Pharmicell Co., Ltd., RTI Surgical Holdings, Inc., AlloSource, Holostem Terapie Avanzate S.R.L., and Medipost Co., Ltd. dominate the market. The participants are focusing their efforts on promoting R&D.
Additionally, they support strategic expansion activities including product introduction, joint ventures, and partnerships to expand their client base and boost their market position. For instance, Thermo Fisher Scientific launched new integrated commercial packaging and distribution services in February 2022. These services were created to help patients in Europe and the US transition from receiving medicines in clinics to using them on the market. In order to support their logistics strategies, developers need the most recent Patheon Commercial Packaging Services, an end-to-end solution that combines distribution, GMP storage, ultracold & cryogenic packaging, and serialization.
Refurbished Medical Devices Market Research Report Information By Diagnostic Devices (X-Ray Machines, CT Scanners, Ultrasound System, MRI Machines, ECG Systems, And Patient Monitors), By Therapeutic Devices (Heart-Lung Machines, Coagulation Analysers, Infant Incubators and Warmers, Defibrillators, and Infusion Pumps), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032
Neuroendoscopy Market Research Report, by Product (Rigid, Flexible Neuroendoscopes), by Application (Transnasal, Intraventricular, Transcranial Neuroendoscopy), by Usability (Reusable, Disposable), End-User (Hospitals) – Global Forecast Till 2030
Dental Software Market Research Report Information By Type (Practice Management Software, Patient Communication Software, Treatment Planning Software, Patient Education Software, and Dental Imaging Software), By Deployment (On-Premise, Web-Based, and Cloud-Based), By End Users (Dental Clinics and Hospitals), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
